Anti-SARS-CoV-2 Immune Responses in Patients Receiving an Allogeneic Stem Cell or Organ Transplant

Patients after autologous (autoSCT) and allogeneic stem cell transplantation (alloSCT) are at an increased risk of COVID-19-related morbidity and mortality, compounded by an immune system weakened by the underlying malignancy and prior treatments. Allogeneic transplantation, including stem cell and...

Descripción completa

Detalles Bibliográficos
Autores principales: Atanackovic, Djordje, Luetkens, Tim, Avila, Stephanie V., Hardy, Nancy M., Lutfi, Forat, Sanchez-Petitto, Gabriela, Vander Mause, Erica, Glynn, Nicole, Mannuel, Heather D., Alkhaldi, Hanan, Hankey, Kim, Baddley, John, Dahiya, Saurabh, Rapoport, Aaron P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310198/
https://www.ncbi.nlm.nih.gov/pubmed/34358153
http://dx.doi.org/10.3390/vaccines9070737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310198/
https://www.ncbi.nlm.nih.gov/pubmed/34358153
http://dx.doi.org/10.3390/vaccines9070737

Ejemplares similares